GlassScriptPhysician profile
Ellen Nong
NPI 1538772371
$1,427.72
in general payments reported to CMS, 2019-2025
22 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $839 · 2024: $132 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $267.63 | 2025 | |
| Boston Scientific Corporation | $227.87 | 2021 | |
| Ge Healthcare | $188.48 | 2025 | |
| Abbvie INC. | $159.82 | 2021 | |
| Merck Sharp & Dohme LLC | $62.75 | 2024 | Keytruda, Lynparza |
| Redhill Biopharma INC. | $57.11 | 2021 | |
| Biodelivery Sciences International, INC. | $52.72 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $52.29 | 2021 | |
| Pacira Therapeutics, INC. | $43.69 | 2021 | |
| Amgen INC. | $38.59 | 2021 | |
| Collegium Pharmaceutical, INC. | $33.72 | 2021 | |
| West Therapeutics Development, LLC | $32.57 | 2021 | |
| Stimwave Technologies Incorporated | $31.36 | 2021 | |
| Melinta Therapeutics, LLC | $30.18 | 2024 | Rezzayo |
| Biomarin Pharmaceutical INC. | $26.83 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.42 | 2024 | |
| Medtronic, INC. | $22.44 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.38 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.85 | 2024 | Libtayo |
| Ibsa Pharma INC. | $14.85 | 2021 | |
| Lilly USA, LLC | $13.15 | 2021 | |
| Almatica Pharma LLC | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Nong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.